Frontlight ResearchEarly access
Diabetic eye disease trials in Israel
1 trial · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
- Where
- Tsrifin
- Age
- 18 years and over
- People
- 1,104 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07705607 · EU 2026-526787-20-00